دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Life-Altering Consequences of Neurocognitive Impairment in Survivors of Pediatric Cancer
Kristina K. Hardy, PhD1,2; Melissa M. Hudson, MD3,4; and Kevin R. Krull, PhD4,5
doi : 10.1200/JCO.21.00211
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1693-1695.
Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer
Lisa M. Jacola, PhD1; Marita Partanen, PhD2; Jurgen Lemiere, PhD3; Melissa M. Hudson, MD1; and Sophie Thomas, PhD4
doi : 10.1200/JCO.20.02444
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1696-1704.
Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only
Ellen van der Plas, PhD1; Arunkumar J. Modi, MBBS, MPH2; Chi Kong Li, MBBS, MD3,4,5; Kevin R. Krull, PhD6,7; and Yin Ting Cheung, PhD8
doi : 10.1200/JCO.20.02322
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1705-1717.
Cognitive Risk in Survivors of Pediatric Brain Tumors
Ade Oyefiade, MA1,2; Iris Paltin, PhD3,4; Cinzia R. De Luca, PhD5,6; Kristina K. Hardy, PhD7,8; David R. Grosshans, MD, PhD9; Murali Chintagumpala, MD10,11; Donald J. Mabbott, PhD1,2; and Lisa S. Kahalley, PhD10,11,12
doi : 10.1200/JCO.20.02338
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1718-1726.
Cognitive Impairment in Survivors of Pediatric Extracranial Solid Tumors and Lymphomas
Rebecca Foster, PhD1,2; Daniel J. Zheng, MD, MHS3; Kelli L. Netson-Amore, PhD4; and Nina S. Kadan-Lottick, MD, MSPH5
doi : 10.1200/JCO.20.02358
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1727-1740.
Aging in Adult Survivors of Childhood Cancer: Implications for Future Care
Ilse Schuitema, PhD1; Tyler Alexander, PhD2; Melissa M. Hudson, MD2,3; Kevin R. Krull, PhD2,4; and Kim Edelstein, PhD5
doi : 10.1200/JCO.20.02534
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1741-1751.
Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact
Nicholas S. Phillips, MD, PhD1; Elizabeth S. Duke, MD2; Hannah-Lise T. Schofield, PhD3,4; and Nicole J. Ullrich, MD, PhD5
doi : 10.1200/JCO.20.02533
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1752-1765.
Biomarkers of Cognitive Impairment in Pediatric Cancer Survivors
AnnaLynn M. Williams, PhD1 and Peter D. Cole, MD2
doi : 10.1200/JCO.20.02436
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1766-1774.
Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment
Shelli R. Kesler, PhD1; Charlotte Sleurs, PhD2,3; Brenna C. McDonald, PhD4; Sabine Deprez, PhD3,5; Ellen van der Plas, PhD6; and Brian J. Nieman, PhD7,8,9
doi : 10.1200/JCO.20.02315
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1775-1785.
Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer
Alicia S. Kunin-Batson, PhD1; James L. Klosky, PhD2; Bonnie Carlson-Green, PhD3; and Tara M. Brinkman, PhD4
doi : 10.1200/JCO.20.02512
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1786-1794.
Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review
Sasja A. Schepers, PhD1; Fiona S. M. Schulte, PhD2; Sunita K. Patel, PhD3; and Kathryn Vannatta, PhD4,5
doi : 10.1200/JCO.20.02516
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1795-1812.
Systematic Review of Educational Supports of Pediatric Cancer Survivors: Current Approaches and Future Directions
Jordan Gilleland Marchak, PhD1,2; Katie A. Devine, PhD3; Melissa M. Hudson, MD4; Lisa A. Jacobson, PhD5; Gisela Michel, PhD6; Shenita R. Peterson, MPH1; Fiona Schulte, PhD7; Claire E. Wakefield, PhD8,9; and Stephen A. Sands, PsyD10
doi : 10.1200/JCO.20.02471
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1813-1823.
Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities
Matthew C. Hocking, PhD1,2; Karin S. Walsh, PsyD3,4; Kristina K. Hardy, PhD3,4; and Heather M. Conklin, PhD5
doi : 10.1200/JCO.20.02327
Journal of Clinical Oncology 39, no. 16 (June 01, 2021) 1824-1832.
